Exclusion of 7 FA cell lines from known complementation groups: summary of all available data
. | Complementation group . | . | . | . | . | . | . | . | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell line . | A . | B . | C . | D1 . | D2 . | E . | F . | G . | |||||||
| EUFA592 | F, M | F | F, M | F, M | V, M | F, M | F, M | F, P, M | |||||||
| EUFA816 | F, P | F | F | F | — | F | P | F, P | |||||||
| BD952 | M | — | M | M | M | M | M | M | |||||||
| EUFA961 | F | F | — | F | V | F | — | — | |||||||
| EUFA696 | F | F | F | F | V | F | P | F | |||||||
| EUFA543 | F, M | F | F, M | F, M | V, M | F, M | M | F, M | |||||||
| AG656 | F, P | F | F | F | V | F | F, P | F, P | |||||||
. | Complementation group . | . | . | . | . | . | . | . | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell line . | A . | B . | C . | D1 . | D2 . | E . | F . | G . | |||||||
| EUFA592 | F, M | F | F, M | F, M | V, M | F, M | F, M | F, P, M | |||||||
| EUFA816 | F, P | F | F | F | — | F | P | F, P | |||||||
| BD952 | M | — | M | M | M | M | M | M | |||||||
| EUFA961 | F | F | — | F | V | F | — | — | |||||||
| EUFA696 | F | F | F | F | V | F | P | F | |||||||
| EUFA543 | F, M | F | F, M | F, M | V, M | F, M | M | F, M | |||||||
| AG656 | F, P | F | F | F | V | F | F, P | F, P | |||||||
F indicates evidence based on cell fusion (Table 1); P, lack of complementation after transfection with the corresponding cDNA in an expression plasmid; V, lack of complementation after retroviral transduction; M, evidence based on segregation of polymorphic markers closely linked to the gene defective in the indicated groups or on absence of homozygosity in patients from consanguineous marriages; and —, no data available.